HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liliana Soroceanu Selected Research

CPT417

11/2016Selective Toxicity of a Highly Potent Camptothecin Analogue: A Pilot Study with Glioblastoma Multiforme Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Liliana Soroceanu Research Topics

Disease

23Neoplasms (Cancer)
01/2022 - 01/2002
11Glioblastoma (Glioblastoma Multiforme)
01/2022 - 02/2007
9Glioma (Gliomas)
11/2016 - 01/2002
6Infections
01/2014 - 12/2007
5Melanoma (Melanoma, Malignant)
01/2021 - 02/2015
2Cholangiocarcinoma
08/2021 - 10/2020
2Neoplasm Metastasis (Metastasis)
06/2015 - 01/2002
2Virus Diseases (Viral Diseases)
12/2013 - 02/2008
2Brain Neoplasms (Brain Tumor)
12/2013 - 05/2012
1Genomic Instability
08/2021
1Cutaneous Malignant Melanoma
01/2021
1Deficiency Diseases (Deficiency Disease)
11/2019
1Lung Neoplasms (Lung Cancer)
01/2018
1Breast Neoplasms (Breast Cancer)
01/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018
1Pain (Aches)
06/2015
1Vomiting
06/2015
1Nausea
06/2015
1Disease Progression
05/2012
1Inflammation (Inflammations)
11/2011
1Cytomegalovirus Infections (Inclusion Disease)
09/2008
1Carcinogenesis
02/2007
1Astrocytoma (Pilocytic Astrocytoma)
02/2007

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
01/2021 - 12/2007
5DNA (Deoxyribonucleic Acid)IBA
01/2021 - 03/2006
3CannabinoidsIBA
01/2022 - 06/2015
3CannabidiolIBA
01/2022 - 03/2013
3Antineoplastic Agents (Antineoplastics)IBA
01/2020 - 12/2013
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 01/2002
3Pharmaceutical PreparationsIBA
01/2020 - 12/2013
3Viral ProteinsIBA
02/2014 - 01/2013
2GemcitabineFDA Link
08/2021 - 10/2020
2Poly(ADP-ribose) Polymerase InhibitorsIBA
08/2021 - 01/2021
2RNA (Ribonucleic Acid)IBA
01/2021 - 01/2019
2IntegrinsIBA
01/2020 - 12/2007
22- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA
01/2020 - 01/2018
2Focal Adhesion Protein-Tyrosine KinasesIBA
01/2020 - 12/2007
2Glycoproteins (Glycoprotein)IBA
02/2014 - 12/2007
2Phosphotransferases (Kinase)IBA
11/2011 - 12/2007
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
02/2008 - 02/2007
1Alkylating AgentsIBA
01/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022
1Temozolomide (Temodar)FDA LinkGeneric
01/2022
1AcidsIBA
08/2021
1DeoxyribonucleotidesIBA
08/2021
1niraparibIBA
08/2021
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
08/2021
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2021
1dinaciclibIBA
10/2020
1Cyclin-Dependent Kinases (cdk Proteins)IBA
10/2020
1VinculinIBA
01/2020
1PaxillinIBA
01/2020
1Complementary DNA (cDNA)IBA
01/2020
1Biological ProductsIBA
01/2020
1Drug CombinationsIBA
01/2020
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2020
1TalinIBA
01/2020
1MicroRNAs (MicroRNA)IBA
08/2019
1Cyclin D1IBA
01/2018
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2017
1CPT417IBA
11/2016
1CamptothecinIBA
11/2016
1cytomegalovirus immediate-early proteinsIBA
08/2015
1NestinIBA
08/2015
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
06/2015
1CB2 Cannabinoid ReceptorIBA
06/2015
1Dronabinol (THC)FDA LinkGeneric
06/2015
1fetal Alzheimer antigenIBA
02/2015
1Small Interfering RNA (siRNA)IBA
02/2015
1Biomarkers (Surrogate Marker)IBA
02/2015
1matrigelIBA
02/2014
1Neutralizing AntibodiesIBA
02/2014
1Interleukin-6 (Interleukin 6)IBA
01/2014
1NucleosidesIBA
12/2013
1Antiviral Agents (Antivirals)IBA
12/2013
1Cidofovir (Vistide)FDA Link
12/2013
1Therapeutic UsesIBA
12/2013
1Stem Cell FactorIBA
01/2013
1GlycosyltransferasesIBA
05/2012
1Laminin (Merosin)IBA
05/2012
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
11/2011
1Platelet-Derived Growth Factor alpha ReceptorIBA
09/2008
1Tyrosine (L-Tyrosine)FDA Link
12/2007
1Epidermal Growth Factor (EGF)IBA
12/2007
1LigandsIBA
12/2007
1Nucleic AcidsIBA
12/2007
1Phospholipases (Phospholipase)IBA
12/2007
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2007
1Messenger RNA (mRNA)IBA
02/2007
1Class Ia Phosphatidylinositol 3-KinaseIBA
02/2007
1Growth Factor ReceptorsIBA
02/2007
1ErbB Receptors (EGF Receptor)IBA
02/2007
1Insulin-Like PeptidesIBA
02/2007
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2007
1Matrix Metalloproteinase 14 (MT1-MMP)IBA
01/2002
1Matrix Metalloproteinases (MMPs)IBA
01/2002

Therapy/Procedure

9Therapeutics
01/2021 - 09/2008
2Drug Therapy (Chemotherapy)
10/2020 - 06/2015
1Self Medication
01/2021
1Radiotherapy
12/2013